Injectable in situ forming nanogel : a hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect

Injectable in situ forming nanogel : a hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect

G.H. Rodrigues da Silva, G. Geronimo, L.N.M. Ribeiro, V.A. Guilherme, L.D. de Moura, A.L. Bombeiro, J.D. Oliveira, M.C. Breitkreitz, E. de Paula

ARTIGO

Inglês

Finding an ideal anesthetic agent for postoperative pain control, with long action and low side effects, is still a challenge. Local anesthetics have potential for such application if their time of action is improved. This work introduces a new hybrid formulation formed by the association of a...

Fechado

Injectable in situ forming nanogel : a hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect

G.H. Rodrigues da Silva, G. Geronimo, L.N.M. Ribeiro, V.A. Guilherme, L.D. de Moura, A.L. Bombeiro, J.D. Oliveira, M.C. Breitkreitz, E. de Paula


										

Injectable in situ forming nanogel : a hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect

G.H. Rodrigues da Silva, G. Geronimo, L.N.M. Ribeiro, V.A. Guilherme, L.D. de Moura, A.L. Bombeiro, J.D. Oliveira, M.C. Breitkreitz, E. de Paula

    Fontes

    Materials science and engineering C: materials for biological applications

    Vol. 109 (Apr., 2020), n. art. 110608